Form D Explorer
Medical 21, Inc. · CIK 1673688

Report a data issueCitable research briefCompare issuerPrivate research collection

Medical 21, Inc.

CIK 1673688 · Corporation · Inc. MINNESOTA · Plymouth, Minnesota · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
1
Amendments
1
Activity
Aug 21, 2025
through Oct 23, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldAug 21, 2025 · D/AOct 23, 2026 · DLater minus earlier
Reported offering amount$20,000,000$20,000,000$0
Reported amount sold$10,017,500$550,000$-9,467,500
Reported investor count—3—
Reported minimum investment$0$0$0

Earlier SEC source: 0001437749-25-027519 · Later SEC source: 0001437749-26-033301

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Oct 23, 2026

Reported offering amount
$20,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$550,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Reg A+ (Form 1-A / 1-K / 1-U) filings by this issuer

Form D filings (2)